 |
|
Purtscher Retinopathy and Necrotizing Vasculitis With Gemcitabine Therapy
Michael J. Banach, MD;
George A. Williams, MD
Royal Oak, Mich
Arch Ophthalmol. 2000;118:726-727.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
A 59-YEAR-OLD man with a 10-year history of diabetes had 2 months of decreasing visual acuity in both eyes. Ten months prior to being seen, the patient began treatment with gemcitabine hydrochloride for non-small-cell lung cancer and within 1 month developed a progressive ischemic peripheral vaso-occlusive disease involving the right fourth digit (Figure 1), the left first digit, left second digit, and the dorsal penis. Findings from an upper extremity arteriogram confirmed sluggish palmar arterial flow bilaterally, and laboratory studies revealed a Westergren erythrocyte sedimentation rate (ESR) of 117 and an antinuclear antibody ratio (ANA) of 1:1280. Gemcitabine administration was discontinued and oral prednisone administration was begun. The peripheral necrotic lesions were stabilized, and within 1 month the ESR was 38. However, the cutaneous lesions persisted with periodic exacerbations during the next 8 months, necessitating varying doses of corticosteroids for . . . [Full Text of this Article]COMMENT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sonography and CT of Vasculitis During Gemcitabine Therapy
Bendix et al.
Am. J. Roentgenol. 2005;184:S14-S15.
FULL TEXT
|
